Reconsidering T component of cancer staging for T3/T4 non-small-cell lung cancer with additional nodule.

Fang Wang,Hang Su,Haoran E,Likun Hou,Minglei Yang,Long Xu,Jiani Gao,Mengmeng Zhao,Junqi Wu,Jiajun Deng,Xiaofeng Xie,Yifan Zhong,Yingze Li,Tingting Wang,Chunyan Wu,Dong Xie,Chang Chen

Therapeutic advances in medical oncology（2022）

引用 3|浏览20

暂无评分

摘要

NSCLC patients with additional nodule(s) in the same lobe and ipsilateral different lobe (maximum tumor diameter ⩽ 3 cm) should be further validated and considered restaging as T2b and T3 in the forthcoming 9th tumor, node, and metastasis staging system.

查看译文

关键词

T3,T4,additional nodule(s),non-small-cell lung cancer,restaging

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要